“A scientific advisory committee to the Food and Drug Administration on Friday overwhelmingly recommended against approving a booster shot of the Pfizer-BioNTech coronavirus vaccine for people 16 and older,” the New York Times reports.
“The committee voted 16 to 3 after holding an intense daylong public discussion on whether booster shots are necessary and if so, for whom. The Biden administration has been hoping the F.D.A. would approve a third shot of the Pfizer vaccine in time to begin rolling out boosters for Pfizer recipients next week.”
Save to Favorites